Xiaohong Xu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Jin, Hong Cen, Ke-Shu Zhou, Xiaohong Xu, Fei Li, Tao Wu, Haiyan Yang, Zhen Wang, Zhi-Ming Li, Wenyang Huang, Hanying Bao, Zusheng Xu, Lugui Qiu
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)